Ivabradine and AF: Coincidence, Correlation or a New Treatment?

Arrhythmia & Electrophysiology Review
Mahmoud AbdelnabiHaitham Badran

Abstract

Ivabradine is a heart rate-lowering agent that inhibits pacemaker funny current (If). It has been approved by the European Medicines Agency and the US Food and Drug Administration for patients with stable angina and heart failure (HF). AF is a common issue especially in ischaemic heart disease and HF patients. In contrast to experimental findings and a limited number of clinical trials that demonstrate the emerging role of ivabradine for heart rate control in AF or maintenance of sinus rhythm, there is accumulating contradictory data indicating that there is, in fact, an increased incidence of new-onset AF among people who are taking ivabradine in clinical practice. This article reviews the most recent evidence highlighting the diversity of data in relation to the use of ivabradine and the onset of AF and whether it has a legitimate role in AF treatment and the maintenance of sinus rhythm.

References

Jun 1, 1987·American Heart Journal·W B KannelL A Cupples
Oct 23, 2004·The Journal of Physiology·Céline MarionneauSophie Demolombe
Oct 11, 2005·European Heart Journal·Jean-Claude TardifUNKNOWN INITIATIVE Investigators
Apr 28, 2006·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Dario DiFrancesco
Dec 18, 2008·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Sheila CarewDeclan Lyons
Jul 27, 2010·Journal of Cardiovascular Electrophysiology·Shomu BohoraApurva Vasavda
Nov 11, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Claire McDonaldJulia L Newton
Sep 15, 2011·Journal of Cardiovascular Electrophysiology·Kazuyoshi SuenariYi-Jen Chen
Jul 23, 2013·Journal of Cardiovascular Electrophysiology·Francesca StillitanoElisabetta Cerbai
May 13, 2014·International Journal of Cardiology·Ghassan MoubarakAlain Cohen Solal
Sep 2, 2014·The New England Journal of Medicine·Kim FoxUNKNOWN SIGNIFY Investigators
Dec 3, 2014·International Journal of Cardiology·Jedrzej KosiukAndreas Bollmann
Feb 7, 2015·Journal of Cardiovascular Electrophysiology·Ester MelesTomaso Gnecchi-Ruscone
Jun 24, 2015·Journal of Molecular and Cellular Cardiology·Simon M BryantClive H Orchard
Aug 5, 2015·Rambam Maimonides Medical Journal·Merav Barzilai, Giris Jacob
Sep 21, 2015·International Journal of Cardiology·Caminiti GiuseppeVolterrani Maurizio
Mar 24, 2016·Journal of Cardiovascular Electrophysiology·Zainab Abdel-Salam, Wail Nammas
Oct 25, 2016·International Journal of Cardiology·Wanwarang WongcharoenArintaya Phrommintikul
May 20, 2017·Revista Española De Cardiología·Adolfo FontenlaMaría López-Gil
Sep 30, 2017·Journal of the American College of Cardiology·Jacob S KoruthSrinivas R Dukkipati
Mar 16, 2019·Journal of the American College of Cardiology·Meredith BryarlyBenjamin D Levine
Jul 28, 2019·Circulation. Arrhythmia and Electrophysiology·Bharatraj BanavalikarMuzaffar Ali

❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery bypass

Clinical Trials Mentioned

NCT03718273

Software Mentioned

IvaBRAdine

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Related Papers

Therapeutic Advances in Cardiovascular Disease
Sarah L TurleyWilliam D Cahoon
Perspective infirmière : revue officielle de l'Ordre des infirmières et infirmiers du Québec
Guy Sabourin
© 2021 Meta ULC. All rights reserved